Daikin Aircon Error code | Daikin AC error code
Decode Daikin aircon error code with our expert...
North America NGS Automation Market: Trends, Opportunities, and Key Drivers to 2031
Meticulous Research®, a leading global market research firm, has released a new report titled "North America NGS Automation Market by Product {Workstations, Consumables}, Sequencing Type {Whole Genome, Exome, Targeted Genome}, Application {Drug Discovery, Diagnostics, Oncology}, End User {Hospitals, Pharmaceutical, Diagnostic Labs} - Forecast to 2030."Download Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5736
According to the latest insights from Meticulous Research®, the North America NGS automation market is projected to grow at a compound annual growth rate (CAGR) of 14%, reaching $776.1 million by 2030. This growth is driven by factors such as the increasing prevalence of cancer, rising demand for NGS automation in laboratories, the need for optimized workflows, and increased pharmaceutical R&D investments and healthcare spending. Additionally, expanding applications of NGS technology and partnerships to develop enhanced library preparation protocols are expected to provide significant growth opportunities for market players. However, the high costs of automation workstations may pose challenges to market expansion.
Future Outlook: North America NGS Automation Market
The North America NGS automation market is categorized into product types {Workstations/Robotic Platforms, Reagents & Consumables}, sequencing types {Whole Genome, Whole Exome, Targeted Genome, Other Sequencing Types}, applications {Drug Discovery, Clinical Diagnostics, and Other Applications}, end users {Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Other End Users}, and countries. The report also analyzes competitors within the industry and provides country-level market share insights.
Browse In Depth: https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736
- By Product: In 2024, workstations/robotic platforms are expected to dominate the market, attributed to the advantages of automated NGS library preparation, including higher efficiency, reduced turnaround times, lower per-sample costs, and greater reproducibility over manual methods. This segment also sees strong demand from pharmaceutical and biotechnology companies for drug discovery purposes.
- By Sequencing Type: Whole genome sequencing is projected to hold the largest market share in 2024, driven by the growing use of NGS in identifying novel drug targets and developing advanced therapeutic techniques, such as targeted, gene, and oligonucleotide therapies.
- By Application: The drug discovery segment is expected to lead the market, with increasing utilization of NGS to identify novel drug targets and develop therapies targeting specific genes and proteins.
- By End User: The pharmaceutical and biotechnology companies segment is anticipated to maintain the largest market share, thanks to rising R&D investments and the increasing demand for new drug discoveries leveraging advanced NGS technologies.
- By Country: The U.S. is expected to hold the largest market share in 2024, supported by robust R&D investments in the pharmaceutical and biotechnology industries, the presence of key NGS automation platform providers, government initiatives promoting genomics research, rising cancer rates, and a favorable reimbursement environment for NGS-based diagnostics.
Quick Buy – North America NGS Automation Market – Opportunity Analysis and Industry Forecast (2024-2030), Research Report: https://www.meticulousresearch.com/Checkout/75503538
Key Market Players
Prominent companies operating in the North America NGS automation market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), Thermo Fisher Scientific Inc. (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland).
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post